anxiety and semaglutide Psychiatric adverse events associated with semaglutide, liraglutide tirzepatide: a pharmacovigilance analysis of individual case safety reports submitted to the EudraVigilance database | International Journal of Clinical Pharmacy Study reveals weight-loss jabs may

Weight gain is caused in part by fluid retention, and may also result from PPAR-gamma activation that results in increased adipose tissue mass, and a central effect to increase feeding (McCulloch, 2015) Notes: these drugs are also euglycemics Black Box Warning: CONGESTIVE HEART FAILURE HEART FAILURE: Thiazolidinediones, including rosiglitazone cause or exacerbate CHF in some patients

Palmitate stimulation of glucagon secretion in mouse pancreatic alpha-cells results from activation of L-type calcium channels and elevation of cytoplasmic calcium

Honda, Y., Kessoku, T., Sumida, Y., Kobayashi, T., Kato, T., Ogawa, Y., Tomeno, W., Imajo, K., Fujita, K., Yoneda, M., Kataoka, K., Taguri, M., Yamanaka, T., Seko, Y., Tanaka, S., Saito, S., Ono, M., Oeda, S., Eguchi, Y.,

Patients with complex comorbidities or polypharmacy concerns should disclose these thoroughly during their initial consultation